TRAF6 ubiquitinates TGFβ type I receptor to promote its cleavage and nuclear translocation in cancer

Transforming growth factor β (TGFβ) is a pluripotent cytokine promoting epithelial cell plasticity during morphogenesis and tumour progression. TGFβ binding to type II and type I serine/threonine kinase receptors (TβRII and TβRI) causes activation of different intracellular signaling pathways. TβRI is associated with the ubiquitin ligase tumor necrosis factor receptor (TNFR)-associated factor 6 (TRAF6). Here we show that TGFβ, via TRAF6, causes Lys63-linked polyubiquitination of TβRI, promoting cleavage of TβRI by TNF-alpha converting enzyme (TACE), in a PKCζ-dependent manner. The liberated intracellular domain (ICD) of TβRI associates with the transcriptional regulator p300 to activate genes involved in tumour cell invasiveness, such as Snail and MMP2. Moreover, TGFβ-induced invasion of cancer cells is TACE- and PKCζ- dependent and the TβRI ICD is localized in the nuclei of different kinds of tumour cells in tissue sections. Thus, our data reveal a specific role for TβRI in TGFβ mediated tumour invasion.

• Publication year

  2011

• Venue

  Nature Communications

• Publication date

  2011-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ncomms1332PMID 21629263PMCID 3113296
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The tail of integrin activation.

  2011cited by this paper
• Conversion of vascular endothelial cells into multipotent stem-like cells

  2010cited by this paper
• What determines the specificity and outcomes of ubiquitin signaling?

  2010cited by this paper
• Cell structure and dynamics.

  2009cited by this paper
• Of the atypical PKCs, Par-4 and p62: recent understandings of the biology and pathology of a PB1-dominated complex

  2009cited by this paper
• TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling.

  2009cited by this paper
• Epithelial-mesenchymal transitions in development and disease.

  2009cited by this paper
• Anti-integrin monoclonal antibodies

  2009cited by this paper
• Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition.

  2009cited by this paper
• Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding.

  2008cited by this paper
• Regulation of apoptosis by PML and the PML-NBs

  2008cited by this paper
• Metalloproteinase- and γ-Secretase-mediated Cleavage of Protein-tyrosine Phosphatase Receptor Type Z*

  2008cited by this paper
• TGFbeta in Cancer.

  2008cited by this paper
• TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta.

  2008cited by this paper
• The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner

  2008cited by this paper
• Signaling by ALK5 mediates TGF-β-induced ET-1 expression in endothelial cells: a role for migration and proliferation

  2007cited by this paper
• Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis.

  2005cited by this paper
• The LIM Protein Ajuba Influences Interleukin-1-Induced NF-κB Activation by Affecting the Assembly and Activity of the Protein Kinase Cζ/p62/TRAF6 Signaling Complex

  2005cited by this paper
• Interaction between Smad7 and β-Catenin: Importance for Transforming Growth Factor β-Induced Apoptosis

  2005cited by this paper
• Shedding light on ADAM metalloproteinases.

  2005cited by this paper
• Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.

  2003cited by this paper
• Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice.

  2003cited by this paper
• TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2.

  2002cited by this paper
• A continuous fluorimetric assay for tumor necrosis factor-alpha converting enzyme.

  2002cited by this paper
• Inhibition of transforming growth factor-beta signaling by low molecular weight compounds interfering with ATP- or substrate-binding sites of the TGF beta type I receptor kinase.

  2002cited by this paper
• TGFβ receptor internalization into EEA1-enriched early endosomes

  2002cited by this paper
• A Continuous Fluorimetric Assay for Tumor Necrosis Factor-α Converting Enzyme

  2002cited by this paper
• Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity.

  2001cited by this paper
• The ubiquitin system.

  1998cited by this paper
• Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells.

  1993cited by this paper
• Human transforming growth factor type beta 2: production by a prostatic adenocarcinoma cell line, purification, and initial characterization.

  1987cited by this paper
• Integrin (cid:1) 1 Signaling Is Necessary for Transforming Growth Factor- (cid:1) Activation of p38MAPK and Epithelial Plasticity*

  year unknowncited by this paper
• Transforming Growth Factor (cid:2) Engages TACE and ErbB3 To Activate Phosphatidylinositol-3 Kinase/Akt in ErbB2-Overexpressing Breast Cancer and Desensitizes Cells to Trastuzumab (cid:1) †

  year unknowncited by this paper

• Talin1 Mediates Tumor-Nerve Interactions in Prostate and Breast Cancer Cells

  2026cites this paper
• MARCH2-mediated Lys63-linked polyubiquitination promotes metastasis by modulating the catalytic activity of TGF-β type I receptor

  2025cites this paper
• Targeting Posttranslational Modifications in the Tumor Stromal Microenvironment for Antitumor Therapy

  2025cites this paper
• Identification of progression markers for prostate cancer

  2025cites this paper
• Transition Metal Phosphides and Nitrides: Advanced Electrodeposition Strategies for Efficient Hydrogen Evolution-Review

  2025cites this paper
• Human transforming growth factor β type I receptor in complex with kinase inhibitor SB505124

  2024cites this paper
• Tumor Necrosis Factor Receptor-Associated Factor 6 and Human Cancer: A Systematic Review of Mechanistic Insights, Functional Roles, and Therapeutic Potential

  2024cites this paper
• A ubiquitination-related risk model for predicting the prognosis and immunotherapy response of gastric adenocarcinoma patients

  2024cites this paper
• Involvement of tumor necrosis factor receptor-associated factor 6 (TRAF6) in NF-κB activation and antiviral immunity: Molecular and functional characterization of TRAF6 in red-spotted grouper (Epinephelus akaara).

  2024cites this paper
• Targeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors

  2024cites this paper
• TRAF1 from a Structural Perspective.

  2024cites this paper
• The TβRI promotes migration and metastasis through thrombospondin 1 and ITGAV in prostate cancer cells

  2024cites this paper
• YWK-II/APLP2 inhibits TGF-β signaling by interfering with the TGFBR2-Hsp90 interaction.

  2023cites this paper
• The Role of TGF-β3 in Radiation Response

  2023cites this paper
• The Ubiquitin–Proteasome System in Tumor Metabolism

  2023cites this paper
• TGF-β as Predictive Marker and Pharmacological Target in Lung Cancer Approach

  2023cites this paper
• Analysis of Moonlighting Proteins Regulated by Curcumin and Resveratrol in Cancer

  2023cites this paper
• Ubiquitin Engineering for Interrogating the Ubiquitin–Proteasome System and Novel Therapeutic Strategies

  2023cites this paper
• TGF-β signaling pathway: Therapeutic targeting and potential for anti-cancer immunity.

  2023cites this paper
• Combined inhibition of surface CD51 and γ-secretase-mediated CD51 cleavage improves therapeutic efficacy in experimental metastatic hepatocellular carcinoma.

  2023cites this paper
• To Ub or not to Ub: a regulatory question in TGF-β signaling.

  2022cites this paper
• Transforming growth factor beta isoforms and TGF-βR1 and TGF-βR2 expression in systemic sclerosis patients

  2022cites this paper
• The Role of Tumor Necrosis Factor Associated Factors (TRAFs) in Vascular Inflammation and Atherosclerosis

  2022cites this paper
• The Synergistic Cooperation between TGF-β and Hypoxia in Cancer and Fibrosis

  2022cites this paper
• Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis

  2022cites this paper
• The ubiquitin-ligase TRAF6 and TGFβ type I receptor form a complex with Aurora kinase B contributing to mitotic progression and cytokinesis in cancer cells

  2022cites this paper
• The type II TGF-β receptor phosphorylates Tyr182 in the type I receptor to activate downstream Src signaling

  2022cites this paper
• Structural feature of TRAFs, their related human diseases and therapeutic intervention

  2021cites this paper
• TGF‐β signaling: A recap of SMAD‐independent and SMAD‐dependent pathways

  2021cites this paper
• Epithelial to Mesenchymal Transition

  2021cites this paper
• Key Matrix Remodeling Enzymes: Functions and Targeting in Cancer

  2021cites this paper
• TRAF4/6 Is Needed for CD44 Cleavage and Migration via RAC1 Activation

  2021cites this paper
• E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression

  2021cites this paper
• Unmasking carcinoma-associated fibroblasts: Key transformation player within the tumor microenvironment.

  2020cites this paper
• Smad7 Enhances TGF-β-Induced Transcription of c-Jun and HDAC6 Promoting Invasion of Prostate Cancer Cells

  2020cites this paper
• microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical In Vivo Models

  2020cites this paper
• TGF-β Signaling

  2020cites this paper
• The Role of TGFβ Signaling in Microglia Maturation and Activation.

  2020cites this paper
• Recent Advances in Understanding Mechanisms of TGF Beta Signaling and Its Role in Glioma Pathogenesis.

  2020cites this paper
• The dichotomous role of TGF-β in controlling liver cancer cell survival and proliferation.

  2020cites this paper
• The Small GTPase RAC1B: A Potent Negative Regulator of-and Useful Tool to Study-TGFβ Signaling

  2020cites this paper
• Mechanisms of TGFβ3 Action as a Therapeutic Agent for Promoting the Synthesis of Extracellular Matrix Proteins in Hyaline Cartilage

  2020cites this paper
• Lys63-Linked Polyubiquitination of Transforming Growth Factor β Type I Receptor (TβRI) Specifies Oncogenic Signaling

  2020cites this paper
• TGFβRI antagonist inhibits HIV-1 Nef-induced CC chemokine family ligand 2 (CCL2) in the brain and prevents spatial learning impairment

  2019cites this paper
• TGFβ Family Signaling Pathways in Pluripotent and Teratocarcinoma Stem Cells’ Fate Decisions: Balancing Between Self-Renewal, Differentiation, and Cancer

  2019cites this paper
• Interactions between TGF-β type I receptor and hypoxia-inducible factor-α mediates a synergistic crosstalk leading to poor prognosis for patients with clear cell renal cell carcinoma

  2019influential citation
• TRAF6 function as a novel co-regulator of Wnt3a target genes in prostate cancer

  2019cites this paper
• TGFβ-induced degradation of TRAF3 in mesenchymal progenitor cells causes age-related osteoporosis

  2019cites this paper
• Review: Targeting the Transforming Growth Factor-Beta Pathway in Ovarian Cancer

  2019influential citation
• Integrated analysis of transcriptome data revealed MMP3 and MMP13 as critical genes in anaplastic thyroid cancer progression

  2019cites this paper
• The role of transforming growth factor ‐ β signaling and hypoxia ‐ inducible factors in renal cell carcinoma

  2019cites this paper
• Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer.

  2019cites this paper
• Specificity, versatility, and control of TGF-β family signaling

  2019cites this paper
• TAK1 mediates convergence of cellular signals for death and survival

  2018cites this paper
• Targeting TGF-β Signaling in Kidney Fibrosis

  2018cites this paper
• Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191

  2018cites this paper
• The role of K63‐linked polyubiquitination in cardiac hypertrophy

  2018cites this paper
• Intracellular trafficking of transforming growth factor &bgr; receptors

  2018cites this paper
• Transforming growth factor-β signaling in systemic sclerosis

  2018cites this paper
• The SUMO System and TGFβ Signaling Interplay in Regulation of Epithelial-Mesenchymal Transition: Implications for Cancer Progression

  2018cites this paper
• Intracellular and extracellular TGF-β signaling in cancer: some recent topics

  2018cites this paper
• TGF-β Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction

  2018cites this paper
• Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma

  2018cites this paper
• TGF-&bgr; signaling in cancer metastasis

  2018cites this paper
• Genetic Alterations of TRAF Proteins in Human Cancers

  2018cites this paper
• Tumor necrosis factor receptor‐associated factor 6 mediated the promotion of salivary adenoid cystic carcinoma progression through Smad‐p38‐JNK signaling pathway induced by TGF‐&bgr;

  2018cites this paper
• TRAF6 regulates proliferation of stromal cells in the transition and peripheral zones of benign prostatic hyperplasia via Akt/mTOR signaling

  2018cites this paper
• Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β

  2018cites this paper
• TGF-β receptors: In and beyond TGF-β signaling.

  2018cites this paper
• Structure of TRAF Family: Current Understanding of Receptor Recognition

  2018cites this paper
• VHL status regulates transforming growth factor-β signaling pathways in renal cell carcinoma

  2018cites this paper
• Title Role of Dlg 5 / lp-dlg , a Membrane-Associated Guanylate Kinase Family Protein , in Epithelial-Mesenchymal Transition in LLc-PK 1 Renal Epithelial Cells

  2018cites this paper
• Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy

  2018cites this paper
• High TRAF6 Expression Is Associated With Esophageal Carcinoma Recurrence and Prompts Cancer Cell Invasion

  2017cites this paper
• Transforming Growth Factor-b Receptors and Smads : Regulatory Complexity and Functional Versatility

  2017cites this paper
• Two Paralogous Tetraspanins TSP-12 and TSP-14 Function with the ADAM10 Metalloprotease SUP-17 to Promote BMP Signaling in Caenorhabditis elegans

  2017cites this paper
• miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition

  2017cites this paper
• C. elegans SMA-10 regulates BMP receptor trafficking

  2017cites this paper
• Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all.

  2017cites this paper
• Receptor activator of nuclear factor kappa B (RANK) expression in primary breast cancer correlates with recurrence-free survival and development of bone metastases in I-SPY1 (CALGB 150007/150012; ACRIN 6657)

  2017cites this paper
• Pro-invasive properties of Snail1 are regulated by sumoylation in response to TGFβ stimulation in cancer

  2017cites this paper
• TGFβ activates PI3K-AKT signaling via TRAF6

  2017cites this paper
• Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.

  2017cites this paper
• TGF-b promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85a

  2017cites this paper
• Non-Smad Signaling Pathways of the TGF-β Family.

  2017cites this paper
• TGFβ and LXR signaling in hepatocellular carcinoma

  2017cites this paper
• Snail acetylation by histone acetyltransferase p300 in lung cancer

  2017cites this paper
• The Ubiquitin E3 Ligase TRAF6 Exacerbates Ischemic Stroke by Ubiquitinating and Activating Rac1

  2017cites this paper
• The potential role of transforming growth factor beta family ligand interactions in prostate cancer

  2017cites this paper
• Regulation of cell polarity and invasion by TGF-β and BMP signaling

  2017cites this paper
• Beyond the quasi-particle: stochastic domain wall dynamics in soft ferromagnetic nanowires

  2017cites this paper
• Investigating the role of the secreted tumour suppressor Dickkopf-3 in stromal-epithelial interactions in prostate cancer

  2017cites this paper
• TARTRATE-RESISTANT ACID PHOSPHATASE / ACP 5 AS A DRIVER OF CANCER : DISSECTION OF ITS ONCOGENIC MECHANISMS AND IDENTIFICATION OF SMALL MOLECULE INHIBITORS

  2017cites this paper
• Influence of the thermal contact resistance in current-induced domain wall depinning

  2017cites this paper
• Depinning process of magnetic domain walls in cylindrical nanowires with a chemical constraint

  2017cites this paper
• TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α

  2017cites this paper
• TGF-β Signaling

  2016influential citation
• Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity

  2016cites this paper
• Development and validation of an LC-MS/MS method for the determination of SB-505124 in rat plasma: Application to pharmacokinetic study.

  2016cites this paper
• Posttranslational Modifications of TGF-β Receptors.

  2016cites this paper